Two people with the coronavirus died in California as much as three weeks before the U.S. reported its first death from the disease in late February — a gap that a top health official said Wednesday may have led to delays in issuing stay-at-home orders in the nation’s most populous state. Dr. Sara Cody, health…
Reports of a respiratory virus spreading in Wuhan, China, emerged in late 2019. After the number of cases outside China increased rapidly, the World Health Organization declared the novel coronavirus a pandemic on March 11. With no cure or vaccine currently available, diagnostic testing is crucial to containing the spread of the virus. Opportunities to…
Get all the latest news on coronavirus and more delivered daily to your inbox. Sign up here.As reporters looked on during a contentious White House briefing this week, President Trump stepped aside and played a brief video showing several media figures downplaying the coronavirus in January and February, including some personalities who now argue the president didn't…
Get all the latest news on coronavirus and more delivered daily to your inbox. Sign up here.There is an increasing belief that the novel coronavirus (COVID-19) originated in a lab in Wuhan, China -- not as a bioweapon -- but as part of Beijing's effort to identify and treat viruses to enhance its own international prestige, according to sources.Multiple sources tell…
Published: October 30, 2026, 10:16 pm Several reports of children choking have led to an FDA warning against Once Upon A Time snacks. The warning covers all flavors, quantities, lots and dates of Once Upon A Farm Tractor Wheels Organic, Toddler Soft-Baked Bars. The FDA has received several reports that describe infants ages 1.5 to
The FDA has cleared the interleukin (IL)-23 inhibitor tildrakizumab (Ilumya) for the treatment of active psoriatic arthritis (PsA) in adults. Sun Pharma announced the approval on October 30. “As an IL-23 inhibitor administered exclusively by a healthcare provider, Ilumya is now an option for adults with active psoriatic arthritis who are unable to self-administer treatment
Millions of Medicare enrollees who buy stand-alone prescription drug plans will see their average monthly premiums rise by 50% in 2027, a new analysis finds. But enrollees can avoid the average increase — from $34 a month to $51 — by switching to lower-cost plans during the program’s open enrollment period, which runs through Dec.